- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Invex Therapeutics Ltd (IXC)
Invex Therapeutics Ltd stock price live, this page displays ASX IXC stock exchange data. View the IXC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Invex Therapeutics Ltd real time stock price chart below.
What Is the Invex Therapeutics Ltd Stock Price Today?
The Invex Therapeutics Ltd stock price today is 0.090.
What Is the Stock Symbol for Invex Therapeutics Ltd?
The stock symbol for Invex Therapeutics Ltd is ""IXC.""
What Stock Exchange Does Invex Therapeutics Ltd Trade On?
Invex Therapeutics Ltd is listed and trades on the Sydney stock exchange.
Is Invex Therapeutics Ltd a Good Stock to Buy?
Determining whether Invex Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IXC quote. (ISIN: AU0000048621)
What Is the Invex Therapeutics Ltd Stock Price Today?
The Invex Therapeutics Ltd stock price today is 0.090.
What Is the Stock Symbol for Invex Therapeutics Ltd?
The stock symbol for Invex Therapeutics Ltd is ""IXC.""
What Stock Exchange Does Invex Therapeutics Ltd Trade On?
Invex Therapeutics Ltd is listed and trades on the Sydney stock exchange.
Is Invex Therapeutics Ltd a Good Stock to Buy?
Determining whether Invex Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IXC quote. (ISIN: AU0000048621)
Sydney
Currency in AUD
0.090
-0.002(-2.17%)
Closed·
Fair Value
An estimate of a Invex Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.090
0.090
52 wk Range
0.059
0.100
IXC Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
IXC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Invex Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0900.090
52 wk Range
0.0590.100
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
IXC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Invex Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Invex Therapeutics Ltd Company Profile
Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase III clinical trial. The company was incorporated in 2019 and is based in Perth, Australia.
Compare IXC to Peers and Sector
Metrics to compare | IXC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIXCPeersSector | |
|---|---|---|---|---|
P/E Ratio | 59.1x | −6.1x | −0.5x | |
PEG Ratio | 0.58 | −0.03 | 0.00 | |
Price/Book | 1.3x | 1.4x | 2.6x | |
Price / LTM Sales | 5.6x | 8.1x | 3.3x | |
Upside (Analyst Target) | - | 214.3% | 43.4% | |
Fair Value Upside | Unlock | 21.9% | 7.1% | Unlock |
Earnings
Latest Release
Feb 06, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Invex Therapeutics Trade On?
Invex Therapeutics is listed and trades on the Sydney Stock Exchange stock exchange.
What Is the Stock Symbol for Invex Therapeutics?
The stock symbol for Invex Therapeutics is "IXC."
What Is the Invex Therapeutics Market Cap?
As of today, Invex Therapeutics market cap is 6.91M.
What Is Invex Therapeutics's Earnings Per Share (TTM)?
The Invex Therapeutics EPS (TTM) is 0.00.
From a Technical Analysis Perspective, Is IXC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Invex Therapeutics Stock Split?
Invex Therapeutics has split 0 times.
How Many Employees Does Invex Therapeutics Have?
Invex Therapeutics has 0 employees.
What is the current trading status of Invex Therapeutics (IXC)?
As of 08 Aug 2025, Invex Therapeutics (IXC) is trading at a price of 0.09, with a previous close of 0.09. The stock has fluctuated within a day range of 0.09 to 0.09, while its 52-week range spans from 0.06 to 0.10.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.